H e m a t o lo g y E d u c a t io n - European Hematology Association
H e m a t o lo g y E d u c a t io n - European Hematology Association
H e m a t o lo g y E d u c a t io n - European Hematology Association
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
16 th Congress of the <strong>European</strong> Hemato<strong>lo</strong>gy Associat<strong>io</strong>n<br />
34. Hue-Roye K, Hipsky CH, Velliquette RW, Fuchisawa A,<br />
Lomas-Francis C, Hoppe C, et al. A novel RHCE*ce 48C, 733G<br />
allele with Nucleotide 941C in Exon 7 encodes an altered red<br />
b<strong>lo</strong>od cell e antigen. Transfus<strong>io</strong>n. Jan;51(1):32-5.<br />
35. Hipsky CH, Lomas-Francis C, Fuchisawa A, Reid ME, Moulds<br />
M, Christensen J, et al. RHCE*ceCF encodes partial c and partial<br />
e but not CELO, an antigen antithetical to Crawford.<br />
Transfus<strong>io</strong>n. Jan;51(1):25-31.<br />
36. Ong J, Walker PS, Schmulbach E, Storry JR, Vege S, Westhoff<br />
C, et al. Al<strong>lo</strong>anti-c in a c-positive, JAL-positive patient. Vox<br />
Sang. 2009 Apr;96(3):240-3.<br />
37. Tournamille C, Meunier-Costes N, Costes B, Martret J,<br />
Barrault A, Gauthier P, et al. Partial C antigen in sickle cell disease<br />
patients: clinical relevance and prevent<strong>io</strong>n of al<strong>lo</strong>immunizat<strong>io</strong>n.<br />
Transfus<strong>io</strong>n. Jan;50(1):13-9.<br />
38. Pham BN, Peyrard T, Juszczak G, Auxerre C, Godin S, Bonin P,<br />
et al. Al<strong>lo</strong>anti-c (RH4) revealing that the (C)ce s hap<strong>lo</strong>type<br />
encodes a partial c antigen. Transfus<strong>io</strong>n. 2009 Jul;49(7):1329-34.<br />
39. Larson PJ, Lukas MB, Friedman DF, Manno CS. Delayed<br />
hemolytic transfus<strong>io</strong>n react<strong>io</strong>n due to anti-Go(a), an antibody<br />
against the <strong>lo</strong>w-prevalence Gonzales antigen. Am J Hematol.<br />
1996 Dec;53(4):248-50.<br />
40. Rouillac C, Gane P, Cartron J, Le Pennec PY, Cartron JP, Colin<br />
Y. Molecular basis of the altered antigenic express<strong>io</strong>n of RhD<br />
in weak D(Du) and RhC/e in RN phenotypes. B<strong>lo</strong>od. 1996 Jun<br />
1;87(11):4853-61.<br />
41. Reid ME, Storry JR, Sausais L, Tossas E, R<strong>io</strong>s M, Hue-Roye K,<br />
et al. DAK, a new <strong>lo</strong>w-incidence antigen in the Rh b<strong>lo</strong>od<br />
group system. Transfus<strong>io</strong>n. 2003 Oct;43(10):1394-7.<br />
42. Cox JV, Steane E, Cunningham G, Frenkel EP. Risk of al<strong>lo</strong>im-<br />
munizat<strong>io</strong>n and delayed hemolytic transfus<strong>io</strong>n react<strong>io</strong>ns in<br />
patients with sickle cell disease. Arch Intern Med. 1988 Nov;<br />
148(11):2485-9.<br />
43. Chadebech P, Habibi A, Nzouakou R, Bachir D, Meunier-<br />
Costes N, Bonin P, et al. Delayed hemolytic transfus<strong>io</strong>n react<strong>io</strong>n<br />
in sickle cell disease patients: evidence of an emerging<br />
syndrome with suicidal red b<strong>lo</strong>od cell death. Transfus<strong>io</strong>n. 2009<br />
Sep;49(9):1785-92.<br />
44. Noizat-Pirenne F, Bachir D, Chadebech P, Michel M, P<strong>lo</strong>nquet<br />
A, Lecron JC, et al. Rituximab for prevent<strong>io</strong>n of delayed<br />
hemolytic transfus<strong>io</strong>n react<strong>io</strong>n in sickle cell disease.<br />
Haemato<strong>lo</strong>gica. 2007 Dec;92(12):e132-5.<br />
45. de Montalembert M, Dumont MD, Heilbronner C, Brousse V,<br />
Charrara O, Pellegrino B, et al. Delayed hemolytic transfus<strong>io</strong>n<br />
react<strong>io</strong>n in children with sickle cell disease. Haemato<strong>lo</strong>gica.<br />
Feb 17.<br />
46. Zimring JC, Spitalnik SL, Roback JD, Hillyer CD. Transfus<strong>io</strong>ninduced<br />
autoantibodies and differential immunogenicity of<br />
b<strong>lo</strong>od group antigens: a novel hypothesis. Transfus<strong>io</strong>n. 2007<br />
Dec;47(12):2189-96.<br />
47. Pham BN, Peyrard T, Juszczak G, Beolet M, Deram G, Martin-<br />
Blanc S, et al. Analysis of RhCE variants among 806 individuals<br />
in France: considerat<strong>io</strong>ns for transfus<strong>io</strong>n safety, with<br />
emphasis on patients with sickle cell disease. Transfus<strong>io</strong>n.<br />
Dec 16.<br />
48. Fasano RM, Monaco A, Meier ER, Pary P, Lee-Stroka AH,<br />
Otridge J, et al. RH genotyping in a sickle cell disease patient<br />
contributing to hematopoietic stem cell transplantat<strong>io</strong>n donor<br />
select<strong>io</strong>n and management. B<strong>lo</strong>od. Oct 14;116(15):2836-8.<br />
| 380 | Hemato<strong>lo</strong>gy Educat<strong>io</strong>n: the educat<strong>io</strong>n programme for the annual congress of the <strong>European</strong> Hemato<strong>lo</strong>gy Associat<strong>io</strong>n | 2011; 5(1)
Change language